| ASCENTAGE PHARMA |
| China |
| Gesundheit |
| KYG0519B1023 / A2PUCQ |
| 36X (Frankfurt) |
| FRA:36X, ETR:36X, 36X:GR |
| - |
| https://www.ascentage.cn/ |
|
Ascentage Pharma Group International is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for cancer, hepatitis, and age-related diseases. Known for its expertise in apoptosis-targete..
>Volltext.. |
| 2128.04 Mio. EUR |
| 2069.52 Mio. EUR |
| 69.41 Mio. EUR |
| -135.33 Mio. EUR |
| -150.05 Mio. EUR |
| -0.42 EUR |
| 245.39 Mio. EUR |
| 306.17 Mio. EUR |
| 143.04 Mio. EUR |
| 1.5 |
| -48.36% |
| -169.63% |
| - |
| - |
| - |
| - |
| ASCENTAGE |
| 04.04.26 |
|